Abbott Laboratories (NYSE:ABT) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies ...
Abbott Labs Medical Devices and Diagnostics segments drive robust growth, with the Exact Sciences acquisition adding value.
Abbott Laboratories is under fresh scrutiny as price targets are reset, with some analysts trimming their expectations and ...
In 2013, Abbott Labs shifted to focus on generics, medical devices, diagnostics, and nutrition. Since then, it has grown its business and become much more robust and diverse. While it has benefited ...
View Abbott Laboratories ABT stock quote prices, financial information, real-time forecasts, and company news from CNN.
Abbott’s ABT first-quarter results demonstrated underlying strength even as the diagnostics segment saw significant declines on diminishing demand for COVID-19 tests. As these dynamics were already ...
Abbott Laboratories trades at 17.7x forward earnings, the lowest valuation multiple in a decade. Read why I rate ABT stock a ...
A Missouri appellate court has upheld a $495 million verdict against Abbott Laboratories in a case over whether its formula ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results